Introduction: New 188Re and 99mTc peptide conjugates with substance-P(SP) were prepared and biologically evaluated. The radiopharmaceuticals have been labelled with the[M =N]2þ (M=99mTc,188Re) core using a combination of π-donor tridentate and π-acceptor monodentate ancillary ligands. Methods: The new radiopharmaceuticals have been prepared through a two-step reaction by simultaneous addition of thetridentate and monodentate ligands to a vial containing a preformed[M=N]2þ core. The tridentate ligand was formed by linking two cysteine residues to the terminal arginine of the undecapeptide SP,where as the monodentate ligand was a tertiary phosphine.The preparation of the corresponding Re-188 derivative required developing a more complex chemical procedure to obtain the [Re = N]2þ core in satisfactory yields. Characterization of the resulting products was obtained by chromatographic methods. Biological evaluation was performed for both Tc-99m and Re-188derivatives by in-vitro studies on isolated cells expressing NK1-receptors. In-vivo imaging in mice was carried out using a small animal YAP(S)PET tomograph. Conclusion: New Tc-99m and Re-188 peptide radiopharmaceuticals with SP have been prepared in high- yield and with high-specific activity. Both Tc-99m and Re-188 peptide radioconjugates exhibit high affinity for NK1 receptors, thus giving further evidence to the empirical rule that structurally related Tc-99m and Re188 radiopharmaceuticals exhibit identical biological properties.

Preparation and first biological evaluation of novel Re-188/Tc-99m peptide conjugates with substance-P

GUERRINI, Remo;PASQUALI, Micol;BOSCHI, Alessandra;UCCELLI, Licia;DI DOMENICO, Giovanni;DUATTI, Adriano
2014

Abstract

Introduction: New 188Re and 99mTc peptide conjugates with substance-P(SP) were prepared and biologically evaluated. The radiopharmaceuticals have been labelled with the[M =N]2þ (M=99mTc,188Re) core using a combination of π-donor tridentate and π-acceptor monodentate ancillary ligands. Methods: The new radiopharmaceuticals have been prepared through a two-step reaction by simultaneous addition of thetridentate and monodentate ligands to a vial containing a preformed[M=N]2þ core. The tridentate ligand was formed by linking two cysteine residues to the terminal arginine of the undecapeptide SP,where as the monodentate ligand was a tertiary phosphine.The preparation of the corresponding Re-188 derivative required developing a more complex chemical procedure to obtain the [Re = N]2þ core in satisfactory yields. Characterization of the resulting products was obtained by chromatographic methods. Biological evaluation was performed for both Tc-99m and Re-188derivatives by in-vitro studies on isolated cells expressing NK1-receptors. In-vivo imaging in mice was carried out using a small animal YAP(S)PET tomograph. Conclusion: New Tc-99m and Re-188 peptide radiopharmaceuticals with SP have been prepared in high- yield and with high-specific activity. Both Tc-99m and Re-188 peptide radioconjugates exhibit high affinity for NK1 receptors, thus giving further evidence to the empirical rule that structurally related Tc-99m and Re188 radiopharmaceuticals exhibit identical biological properties.
Katarina, Smilkov; Emilija, Janevik; Guerrini, Remo; Pasquali, Micol; Boschi, Alessandra; Uccelli, Licia; DI DOMENICO, Giovanni; Duatti, Adriano
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/2022212
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 25
  • ???jsp.display-item.citation.isi??? 24
social impact